IFG Advisory’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$589K Buy
+13,796
New +$749K 0.02% 563
2026
Q1
Sell
-16,966
Closed -$1.62M 385
2025
Q4
$1.62M Buy
16,966
+10,856
+178% +$1.06M 0.07% 281
2025
Q3
$597K Sell
6,110
-1,876
-23% -$194K 0.03% 458
2025
Q2
$858K Buy
7,986
+87
+1% +$8.8K 0.04% 381
2025
Q1
$797K Buy
7,899
+448
+6% +$45.1K 0.04% 360
2024
Q4
$666K Buy
+7,451
New +$656K 0.04% 362
2024
Q3
Sell
-5,363
Closed -$413K 410
2024
Q2
$413K Buy
+5,363
New +$393K 0.03% 436
2023
Q2
Sell
-4,529
Closed -$227K 339
2023
Q1
$227K Buy
+4,529
New +$213K 0.02% 467

Other funds holding BSX

IFG Advisory's BSX Position: Q2 2026 in Review

IFG Advisory opened a new position in Boston Scientific (BSX) in Q2 2026: 13,796 shares worth $589K. The stake represents 0.02% of the portfolio and ranks #563 among its holdings. This is a return to the name: IFG Advisory previously reported a position in BSX as recently as Q4 2025.

IFG Advisory first reported a position in BSX in Q1 2023 and has held it in 8 quarters since. The position peaked at $1.62M in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • IFG Advisory held 13,796 shares of Boston Scientific worth $589K as of Q2 2026.
  • Boston Scientific was a new IFG Advisory position in Q2 2026.
  • Boston Scientific made up 0.02% of IFG Advisory's portfolio in Q2 2026, its #563 holding.
  • IFG Advisory first reported a position in Boston Scientific in Q1 2023 and has held it in 8 quarters since.
  • IFG Advisory's Boston Scientific position peaked at $1.62M in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on IFG Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.